Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Lisa A Cavacini"'
Autor:
Raquel A Binder, Angela M Matta, Catherine S Forconi, Cliff I Oduor, Prajakta Bedekar, Paul N Patrone, Anthony J Kearsley, Boaz Odwar, Jennifer Batista, Sarah N Forrester, Heidi K Leftwich, Lisa A Cavacini, Ann M Moormann
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307568 (2024)
COVID-19 disproportionately affected minorities, while research barriers to engage underserved communities persist. Serological studies reveal infection and vaccination histories within these communities, however lack of consensus on downstream evalu
Externí odkaz:
https://doaj.org/article/af5fe2c4d9a741759299e9a7aca30c1e
Autor:
Caleb M Ardizzone, Hannah L Albritton, Rebecca A Lillis, Caitlyn E L Bagnetto, Li Shen, Lisa A Cavacini, Pamela A Kozlowski, Alison J Quayle
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258759 (2021)
The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-deriv
Externí odkaz:
https://doaj.org/article/d2881289f46540c5a3f7e24a73f687bb
Autor:
Agnes S Lo, Xuming Mao, Eric M Mukherjee, Christoph T Ellebrecht, Xiaocong Yu, Marshall R Posner, Aimee S Payne, Lisa A Cavacini
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156800 (2016)
Pemphigus vulgaris (PV) is characterized by IgG1 and IgG4 autoantibodies to desmoglein (Dsg) 3, causing suprabasal blistering of skin and mucous membranes. IgG4 is the dominant autoantibody subclass in PV and correlates with disease activity, whereas
Externí odkaz:
https://doaj.org/article/78fbaa4f7347464dba197027fdbfc74c
Autor:
Christina Farr, John F Nomellini, Evan Ailon, Iryna Shanina, Sassan Sangsari, Lisa A Cavacini, John Smit, Marc S Horwitz
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65965 (2013)
The HIV/AIDS pandemic remains an enormous global health concern. Despite effective prevention options, 2.6 million new infections occur annually, with women in developing countries accounting for more than half of these infections. New prevention str
Externí odkaz:
https://doaj.org/article/c9b931ab1e474ae08913a53ae747815f
Autor:
John F Nomellini, Carmen Li, Danielle Lavallee, Iryna Shanina, Lisa A Cavacini, Marc S Horwitz, John Smit
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10366 (2010)
The development of alternative strategies to prevent HIV infection is a global public health priority. Initial efforts in anti-HIV microbicide development have met with poor success as the strategies have relied on a non-specific mechanism of action.
Externí odkaz:
https://doaj.org/article/fa5791d9039049a8a855322f20046461
Autor:
H. M. Emranul Haque, Monir Ejemel, David J. Vance, Graham Willsey, Michael J. Rudolph, Lisa A. Cavacini, Yang Wang, Nicholas J. Mantis, David D. Weis
Publikováno v:
ACS Infectious Diseases. 8:2515-2528
The Lyme disease (LD) vaccine formerly approved for use in the United States consisted of recombinant outer surface protein A (OspA) from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679f608a3f20256d6f13d185b32211fa
https://doi.org/10.1021/acsinfecdis.2c00346
https://doi.org/10.1021/acsinfecdis.2c00346
Autor:
Sakshi Bajoria, Lorena R. Antunez, Ozan S. Kumru, Mark Klempner, Yang Wang, Lisa A. Cavacini, Sangeeta B. Joshi, David B. Volkin
Publikováno v:
Journal of Pharmaceutical Sciences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a491a44495b5ec077a25fac8f315af
https://doi.org/10.1016/j.xphs.2023.04.005
https://doi.org/10.1016/j.xphs.2023.04.005
Autor:
Qi Li, Fiachra Humphries, Roxie C. Girardin, Aaron Wallace, Monir Ejemel, Alla Amcheslavsky, Conor T. McMahon, Zachary A. Schiller, Zepei Ma, John Cruz, Alan P. Dupuis, Anne F. Payne, Arooma Maryam, Nese Kurt Yilmaz, Kathleen A. McDonough, Brian G. Pierce, Celia A. Schiffer, Andrew C. Kruse, Mark S. Klempner, Lisa A. Cavacini, Katherine A. Fitzgerald, Yang Wang
Publikováno v:
Frontiers in immunology. 13
Anti-COVID antibody therapeutics have been developed but not widely used due to their high cost and escape of neutralization from the emerging variants. Here, we describe the development of VHH-IgA1.1, a nanobody IgA fusion molecule as an inhalable,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff963d1c57cb77946b938932143bd61
https://pubmed.ncbi.nlm.nih.gov/36172366
https://pubmed.ncbi.nlm.nih.gov/36172366
Autor:
Mark S. Klempner, Matteo Stoppato, Alla Amcheslavsky, Jessica R. Pondish, Jordan Meisinger, Monir Ejemel, Ryan Schneider, Aaron Wallace, Qi Li, Yang Wang, Jacqueline R. Toomey, Raimond Heukers, Serena Giuntini, Lisa A. Cavacini, Eileen M. Barry, Zachary A. Schiller, Conor McMahon, Brian G. Pierce, Andrew C. Kruse
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports
Scientific Reports
Enterotoxigenic Escherichia coli (ETEC) is estimated to cause approximately 380,000 deaths annually during sporadic or epidemic outbreaks worldwide. Development of vaccines against ETEC is very challenging due to the vast heterogeneity of the ETEC st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078cfdfd96ee937b4c593bb60c08d2bb
https://doaj.org/article/8c71423749de4016b747f5338a446935
https://doaj.org/article/8c71423749de4016b747f5338a446935
Autor:
Mark S. Klempner, Michael J. Elmore, Zachary A. Schiller, Naomi Coombes, Mohsan Saeed, Brianna J. Close, Anudeep S. Ramchetty, Kerry J Godwin, Chandrashekar Ganesa, Hasahn L. Conway, Lisa A. Cavacini, Miles W. Carroll, Julia A. Tree, Shurong Hou, Jacqueline R. Toomey, Aaron Wallace, Da Yuan Chen, Celia A. Schiffer, Karen R. Buttigieg, Monir Ejemel, Ryan Schneider, Qi Li, Yang Wang, Alla Amcheslavsky, Nese Kurt Yilmaz
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
bioRxiv
Nature Communications
bioRxiv
Nature Communications
COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development of interventions for the prevention or treatment to curtail mortality and morbidity. No vaccine to boost mucosal immunity, or as a therapeutic, has yet been develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b3b0f26b99337f8cf3e2daea8e6a5e4
http://link.springer.com/article/10.1038/s41467-020-18058-8
http://link.springer.com/article/10.1038/s41467-020-18058-8